Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
Intravenous heparin is routinely given after thrombolytic therapy for patients with acute myocardial infarction in the United States and in some, but by no means all, other countries. Several trials have documented improved infarct-artery patency in patients treated with heparin; however, none was l...
Những tác giả chính: | Mahaffey, K, Granger, C, Collins, R, O'Connor, C, Ohman, E, Bleich, S, Col, J, Califf, R |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1996
|
Những quyển sách tương tự
-
Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
Bằng: I. S. Yavelov
Được phát hành: (2009-12-01) -
Intravenous thrombolytic therapy in myocardial infarction (review)
Bằng: I I Staroverov
Được phát hành: (2003-10-01) -
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
Bằng: Collins, R, et al.
Được phát hành: (1987) -
RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
Bằng: Collins, R
Được phát hành: (1987) -
HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION
Bằng: Macmahon, S, et al.
Được phát hành: (1992)